Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575809 · ClinicalTrials.gov registry record
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
A clinical trial of Peripheral Blood Stem Cell Transplantation, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 633
- Enrollment target
- 2
- Study locations
NCT00575809: Completed study of Peripheral Blood Stem Cell Transplantation, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00575809 is a study of Peripheral Blood Stem Cell Transplantation that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 633 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00575809, a study of Peripheral Blood Stem Cell Transplantation, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 633 participants
- Enrollment target
- 2
- Study locations
Study Summary
Our study intends to evaluate prospectively the incidence and severity of oral mucositis in patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, as well as to evaluate the potential influence of nutritional-, physical-, and transplant-related factors associated with the development of this complication and its grade of involvement.
Conditions Studied
Interventions
- OTHER Mucositis and nutritional assessments
Study Locations (2)
Texas
- Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division - San Antonio
- The University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 633 participants |
| Start Date | 2005-05 |
| Est. Completion | 2021-07-15 |
What the finished NCT00575809 record still lists
NCT00575809 is an observational study that tracks outcomes without assigning an intervention. The registered 633 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Peripheral Blood Stem Cell Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Mucositis and nutritional assessments is the first listed.
NCT00575809 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00575809 about?
NCT00575809 is a clinical study titled "Incidence and Factors Associated With the Development and Severity of Oral Mucositis". Our study intends to evaluate prospectively the incidence and severity of oral mucositis in patients undergoing high-dose chemotherapy and hematopoietic stem cell transplantation, as well as to evaluate the potential influence of nutritional-, physical-, and transplant-related factors associated wit...
What is the current status of trial NCT00575809?
This trial is currently completed. The enrollment target is 633 participants. The study started on 2005-05. Estimated completion is 2021-07-15.
What conditions does trial NCT00575809 study?
This clinical trial studies the following conditions: Peripheral Blood Stem Cell Transplantation.
What interventions are being tested in trial NCT00575809?
The interventions under investigation include: Mucositis and nutritional assessments (OTHER).
Who is sponsoring clinical trial NCT00575809?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00575809 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Blood Stem Cell Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RECRUITING · Phase 1
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia